Updated September 2026Every dose tier pricedRehydra+ Wellness review
Three dose tiers on each molecule, each with its own figure, and a separate price for buying without a subscription.
The verdict
Rehydra+ Wellness publishes a three-tier dose ladder on both molecules, read August 2026: semaglutide at $119, $169 and $229 a month, and tirzepatide at $169, $289 and $419.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Rises with dose
- From
- $119/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Rehydra+ Wellness sells both molecules by injection on a subscription with priced dose tiers, alongside one-time vials for buyers who do not want a standing order.
Who writes the prescription, and what do they see?
A prescription precedes dispensing and the clinician is not described. The tier structure implies a clinical decision at each step and the pages do not describe who makes it.
Publishing what each dose costs is the substantive disclosure here, and it is rare enough to be the reason to look. Most sellers answer the escalation question with a single word or with silence; this one answers it with a number at every rung, which lets a reader cost out a year before starting one.
What happens when the dose goes up?
This is the field Rehydra+ answers better than most. Semaglutide runs $119, $169 and $229 across three tiers, and tirzepatide $169, $289 and $419 — so reaching the top tier costs $110 and $250 more a month than the entry one. A buyer who expects to escalate knows the number today.
What the price includes
Six months at the entry semaglutide tier is $714 and at the top tier $1,374. One-time non-subscription vials start at $149 and $219, so declining the standing order costs $30 and $50 more a month. A separate 2.5 mg listing runs $399 to $479, which is a different product line from the tiered ladder.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy the site does not name, and not reviewed by the FDA before dispensing as an approved product is.
Where it holds up, and where it does not
- Strength: Three priced dose tiers on each molecule
- Strength: One-time vials priced as an alternative
- Strength: The cost of escalating is knowable today
- Limitation: The top tirzepatide tier reaches $419
- Limitation: Declining the subscription costs more
- Limitation: A separate listing runs to $479
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Rehydra+ Wellness. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants to price a full escalation before committing to a first dose.
- Wrong for
- A reader comparing entry figures as though they were rates, when the top tirzepatide tier is $419 and declining the subscription costs more.
How Rehydra+ Wellness compares
| Seller | Who it suits | Go |
|---|---|---|
| Rejuve Meds | Readers who will prepay a year and have read the footnote under the label | See Rejuve Meds → |
 Regenics | Readers who will add the membership to the medication before comparing anything | See Regenics → |
| RestorLife Med | Readers who want monitoring included rather than billed separately | See RestorLife Med → |
More GLP-1 telehealth sellers reviews: LevityLibertyLifeMDLiv BodyLive VitalLivea
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What happens to the price as my dose rises?
- It rises with it and every step is published: semaglutide at $119, $169 and $229, and tirzepatide at $169, $289 and $419.
- Can I buy without subscribing?
- Yes. One-time vials start at $149 for semaglutide and $219 for tirzepatide, which is $30 and $50 above the entry subscription tiers.
- What is the 2.5 mg listing?
- A separate product running $399 to $479, distinct from the tiered ladder.
- Is Rehydra+ Wellness expensive compared with other GLP-1 telehealth sellers?
- Rehydra+ Wellness publishes a starting figure of $119/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Rehydra+ Wellness below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.